195 related articles for article (PubMed ID: 7086816)
1. Enhanced antitumor properties of 3'-(4-morpholinyl) and 3'-(4-methoxy-1-piperidinyl) derivatives of 3'-deaminodaunorubicin.
Mosher CW; Wu HY; Fujiwara AN; Acton EM
J Med Chem; 1982 Jan; 25(1):18-24. PubMed ID: 7086816
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antileukemic activity of N-enamine derivatives of daunorubicin, 5-iminodaunorubicin, and doxorubicin.
Stefańska B; Dzieduszycka M; Bontemps-Gracz M; Borowski E; Martelli S
J Antibiot (Tokyo); 1988 Feb; 41(2):193-8. PubMed ID: 3356607
[TBL] [Abstract][Full Text] [Related]
3. Intensely potent morpholinyl anthracyclines.
Acton EM; Tong GL; Mosher CW; Wolgemuth RL
J Med Chem; 1984 May; 27(5):638-45. PubMed ID: 6716401
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antitumor activity of 7-O-(2,6-dideoxy-2-fluoro-alpha-L-talopyranosyl) daunomycinone derivatives modified at C-3' or C-4'.
Takagi Y; Kobayashi N; Chang MS; Lim GJ; Tsuchiya T
Carbohydr Res; 1998 Feb; 307(3-4):217-32. PubMed ID: 9675364
[TBL] [Abstract][Full Text] [Related]
5. New N-amino acid derivatives of daunorubicin.
Dzieduszycka M; Stefanska B; Borowski E; Martelli S
Farmaco Sci; 1986 Nov; 41(11):881-91. PubMed ID: 3803566
[TBL] [Abstract][Full Text] [Related]
6. DNA topoisomerase II-mediated interaction of doxorubicin and daunorubicin congeners with DNA.
Bodley A; Liu LF; Israel M; Seshadri R; Koseki Y; Giuliani FC; Kirschenbaum S; Silber R; Potmesil M
Cancer Res; 1989 Nov; 49(21):5969-78. PubMed ID: 2551497
[TBL] [Abstract][Full Text] [Related]
7. 3'-Hydroxyesorubicin halogenated at C-2'.
Priebe W; Neamati N; Perez-soler R
J Antibiot (Tokyo); 1992 Mar; 45(3):386-93. PubMed ID: 1577666
[TBL] [Abstract][Full Text] [Related]
8. Adriamycin analogues. Preparation and biological evaluation of some N-perfluoroacyl analogues of daunorubicin, adriamycin, and N-(trifluoroacetyl)adriamycin 14-valerate and their 9,10-anhydro derivatives.
Israel M; Potti G
J Med Chem; 1982 Feb; 25(2):187-91. PubMed ID: 7057426
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antitumor activity of optically active (+)-9-O-alpha-L-daunosaminyl-4-demethoxydaunorubicin.
Kimura Y; Matsumoto T; Suzuki M; Terashima S
J Antibiot (Tokyo); 1985 Sep; 38(9):1277-9. PubMed ID: 4066509
[No Abstract] [Full Text] [Related]
10. Synthesis of daunorubicin analogues with novel 9-acyl substituents.
Smith TH; Fujiwara AN; Henry DW
J Med Chem; 1979 Jan; 22(1):40-4. PubMed ID: 423182
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antitumor activity of novel 4-demethoxyanthracyclines.
Adams N; Blake C; Broadhurst MJ; Bushnell DJ; Hassall CH; Hartmann HR; Keech E; Stratton AR; Thomas GJ
J Med Chem; 1990 Sep; 33(9):2375-9. PubMed ID: 2391681
[TBL] [Abstract][Full Text] [Related]
12. Sugar-ring analogs of daunorubicin: 3'-epidaunorubicin, 3'-hydroxy-3',5'-diepidaunorubicin and 3',6'-dihydroxy-3',5'-diepidaunorubicin.
Cheung TM; Horton D; Priebe W; Turner WR; Weckerle W
J Antibiot (Tokyo); 1985 May; 38(5):683-6. PubMed ID: 4019314
[No Abstract] [Full Text] [Related]
13. Synthesis, biological and biochemical properties of new anthracyclines modified in the aminosugar moiety.
Bargiotti A; Casazza AM; Cassinelli G; Di Marco A; Penco S; Pratesi G; Supino R; Zaccara A; Zunino F; Arcamone F
Cancer Chemother Pharmacol; 1983; 10(2):84-9. PubMed ID: 6831630
[TBL] [Abstract][Full Text] [Related]
14. [Derivatives of antineoplastic antibiotics of the daunorubicin series containing methylurea or nitrosomethylurea residues].
Povarov LS; Bakina EV; Lazhko EI; Orlova GI; Zhukova OS; Obidniak NA; Iurchenko GI; Glazkova TIu; Preobrazhenskaia MN
Bioorg Khim; 1990 Apr; 16(4):559-68. PubMed ID: 2375780
[TBL] [Abstract][Full Text] [Related]
15. [Models of preclinical studies of anthracyclines].
Fizames C
Pathol Biol (Paris); 1987 Jan; 35(1):41-8. PubMed ID: 3550611
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological activity of the two isomeric 2'-C-methyl daunomycins.
Rocherolle V; Olesker A; Lukacs G
J Antibiot (Tokyo); 1989 Sep; 42(9):1393-7. PubMed ID: 2793594
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antitumor activity of 2'-bromo- and 2'-chloro-3'-acetoxy-3'-deaminodaunorubicin analogs.
Horton D; Priebe W; Varela O
Carbohydr Res; 1985 Dec; 144(2):305-15. PubMed ID: 4092209
[TBL] [Abstract][Full Text] [Related]
18. Cellular pharmacology and antitumor activity of N-(p-azidobenzoyl)-daunorubicin, a photoactive anthracycline analogue.
Averbuch SD; Clawson RE; Bachur NR; Felsted RL
Cancer Chemother Pharmacol; 1986; 16(3):211-7. PubMed ID: 2421935
[TBL] [Abstract][Full Text] [Related]
19. Activity of SC33428, a novel bishydrazone-bridged derivative of 4-demethoxydaunorubicin, against experimental tumors in mice.
Dawson KM
Cancer Res; 1983 Jun; 43(6):2880-3. PubMed ID: 6573953
[TBL] [Abstract][Full Text] [Related]
20. Antileukemic activity of 4-demethoxydaunorubicin in mice.
Casazza AM; Pratesi G; Giuliani F; Di Marco A
Tumori; 1980 Oct; 66(5):549-64. PubMed ID: 6936969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
